Clinical trial

Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer

NCT01087580

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE2

Study timeline

Study start (unknown)2011-03-01Date precision: month

Registry last updated2017-03-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

PROSTATE CANCERunresolved

Interventions

Docetaxel and PrednisoneDRUG

Radiation TherapyDRUG

Sponsors & collaborators

Northwestern Universitylead sponsor

Genzyme, a Sanofi Companycollaborator

Mapped research locations

ChicagoIllinois, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01087580 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.